CHINAHEALTHWISE (00348) to receive a full takeover offer at a premium of approximately 9.59%; trading to resume on November 19

date
19:37 18/11/2026
avatar
GMT Eight
China Healthwise (00348) and the offeror Huasheng International Investment Limited jointly announced that on September 18, 2026, the offeror intends to acquire approximately 188 million sale shares from Seller One (Eternal Financial Group Limited and Mr. Li Xiongwei) (equivalent to approximately 37,541,300 consolidated sale shares after the share consolidation), representing approximately 20.30% of the total issued share capital of the company as at the date of this joint announcement, for a total consideration of approximately HK$15.0165 million in cash, equivalent to HK$0.08 per sale share.
CHINAHEALTHWISE (00348) and the offeror Huasheng International Investment Limited jointly announced that on September 18, 2026, the offeror proposed to acquire approximately 188 million sale shares from Seller One (Eternal Finance Group Limited and Mr. Li Xiongwei) (equivalent to approximately 37,541,300 consolidated sale shares after the share consolidation), representing approximately 20.30% of the total issued share capital of the company as at the date of this joint announcement, for a total consideration of approximately HK$15.0165 million in cash, equivalent to HK$0.08 per sale share. On September 20, the offeror proposed to acquire 117.5 million sale shares from Seller Two (namely Mr. Tang Qinghe, Ms. Chen Shuqiong, Mr. Zhou Liqian and Success Profile Inc.) (equivalent to 23.5 million consolidated sale shares after the share consolidation), representing approximately 12.71% of the total issued share capital of the company as at the date of this joint announcement, for a total consideration of HK$9.4 million in cash, equivalent to HK$0.08 per sale share. Immediately following completion, the offeror, its ultimate beneficial owners and any persons acting in concert with any of them will have interests in a total of approximately 305 million existing shares, representing approximately 33.01% of the issued share capital of the company as at the date of this joint announcement. Accordingly, under Rule 26.1 of the Takeovers Code, the offeror will be required to make a mandatory conditional cash offer for all issued shares (other than those already owned and/or agreed to be acquired by the offeror, its ultimate beneficial owners and any persons acting in concert with any of them). The offer price is HK$0.08 in cash per offer share, representing a premium of approximately 9.59% over the closing price of HK$0.0730 per share as quoted on the Stock Exchange on September 18, 2026. In addition, the company has applied to the Stock Exchange for resumption of trading in its shares with effect from 9:00 a.m. on November 19, 2026. It is understood that the offeror is wholly owned by Shenglongyi, and Shenglongyi is wholly owned by Mr. Jin Peng, the ultimate beneficial owner of the offeror.